Here is a direct quote from the Excellarate phase 1 and 2 trials about the safety of Excellarate, I think you have some bad info. Here is the quote:

Phase 1/2 Excellarate Clinical Study

Excellarate has been studied in a Phase 1/2 clinical trial that evaluated safety and included a preliminary assessment of healing. The positive findings of this open label multi-center Phase 1/2 Excellarate clinical study were published in the November-December 2009 issue of Wound Repair and Regeneration, a peer-reviewed journal of the Wound Healing Society. The principal findings of the study concluded that Excellarate appeared to be both safe and well tolerated and that complete wound closure was observed at 14 weeks in 10 of the 15 patients (67%), seven of whom had received only a single application of the Excellarate product candidate. In addition, Excellarate appeared to be associated with early rapid healing responses (around half of the patients achieved a 50-99% reduction in wound size by week 2).

If you would have read about Excellegan you would see that its the collogen in it that is doing the healing so its not genetic insertion, thats why its being expedited by using the 510(K) fast track approval from FDA, so I do believe it will get approval. So will the other products.

There has been no drugs approved by the FDA using genetic insertion/modification techniques....hope you didn't put too much money in this stock.  Also, check out the adverse events that occurred on Excellarate....that's why the FDA won't approve this particular drug.